HomeCompareFPHHF vs PFE

FPHHF vs PFE: Dividend Comparison 2026

FPHHF yields 2.76% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $25.6K in total portfolio value· pulled ahead in Year 9
10 years
FPHHF
FPHHF
● Live price
2.76%
Share price
$1.39
Annual div
$0.04
5Y div CAGR
0.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.0K
Annual income
$356.27
Full FPHHF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — FPHHF vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFPHHFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FPHHF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FPHHF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FPHHF
Annual income on $10K today (after 15% tax)
$234.96/yr
After 10yr DRIP, annual income (after tax)
$302.83/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $22,017.07/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FPHHF + PFE for your $10,000?

FPHHF: 50%PFE: 50%
100% PFE50/50100% FPHHF
Portfolio after 10yr
$36.8K
Annual income
$13,307.50/yr
Blended yield
36.18%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

FPHHF
No analyst data
Altman Z
1.2
Piotroski
6/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FPHHF buys
0
PFE buys
0
No recent congressional trades found for FPHHF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFPHHFPFE
Forward yield2.76%6.13%
Annual dividend / share$0.04$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0.7%13.2%
Portfolio after 10y$24.0K$49.6K
Annual income after 10y$356.27$26,258.71
Total dividends collected$3.2K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: FPHHF vs PFE ($10,000, DRIP)

YearFPHHF PortfolioFPHHF Income/yrPFE PortfolioPFE Income/yrGap
1$10,978$278.36$9,153$693.39+$1.8KFPHHF
2$12,034$287.60$8,593$849.25+$3.4KFPHHF
3$13,174$296.70$8,336$1,066.78+$4.8KFPHHF
4$14,401$305.67$8,437$1,384.80+$6.0KFPHHF
5$15,724$314.48$9,013$1,875.40+$6.7KFPHHF
6$17,148$323.14$10,306$2,680.72+$6.8KFPHHF
7$18,680$331.66$12,820$4,101.38+$5.9KFPHHF
8$20,327$340.01$17,673$6,826.70+$2.7KFPHHF
9← crossover$22,099$348.22$27,543$12,591.86$5.4KPFE
10$24,002$356.27$49,560$26,258.71$25.6KPFE

FPHHF vs PFE: Complete Analysis 2026

FPHHFStock

First Philippine Holdings Corporation engages in the power generation, real estate development, manufacturing, and construction and others business in the Philippines. It generates power through natural gas-fired, hydroelectric, geothermal, and wind and solar power plants. The company also develops residential and commercial projects; operates cinema and hotels; develops and manages industrial estate; leases, owns, acquires, and sells real and personal properties, and land; maintains and cleans buildings and other facilities; supplies water; and provides waste management and sewage treatment facilities. In addition, it offers dry-type and fluid-immersed transformers, and electronic and electrical products; and packaged substation, project, technical services, and other power solutions. Further, the company constructs power plants, transmission lines, public infrastructure, and electro-mechanical works; provides drilling and workover services for exploratory or development geothermal wells; rents and leases trucks, tractors, vans, buses, trailers, light and heavy equipment, and other motor vehicles; produces, develops, and crushes concrete aggregates and other related products; and supplies petroleum products. Additionally, it is involved in the retail and office leasing activities; hauling, trucking, and delivery of goods and materials; quarrying and the production of rocks, stones, and other related products; provision of transport for trading and distribution, and specialized medical services; oil transporting, securities transfer, medical and research, education, financing, and other activities; and construction and operation of liquid or gas pipeline. The company was formerly known as Meralco Securities Corporation and changed its name to First Philippine Holdings Corporation in September 1972. The company was incorporated in 1961 and is based in Pasig, the Philippines. First Philippine Holdings Corporation is a subsidiary of Lopez Holdings Corporation.

Full FPHHF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this FPHHF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FPHHF vs SCHDFPHHF vs JEPIFPHHF vs OFPHHF vs KOFPHHF vs MAINFPHHF vs JNJFPHHF vs MRKFPHHF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.